Nemaura Medical Inc.
Company Snapshot: Nemaura Medical Inc.
Nemaura Medical Inc., a medical technology company, discovers, develops, and commercializes specialty medical devices. It provides sugarBEAT, a non-invasive continuous glucose monitoring device for use by persons with Type I and Type II diabetes, as well as for screening pre-diabetic patients. The company was founded in 2009 and is headquartered in Loughborough, the United Kingdom.
- Jul 18 2019 Nemaura Medical Inc. Appoints Chris Avery as Vice President of Global Business Operations to Support Global Commercial Launch of SugarBEAT®
- Jul 10 2019 Nemaura Medical Inc. Submits De Novo 510(k) Application for SugarBEAT® to the U.S. Food and Drug Administration
- Jun 17 2019 Nemaura Provides Fiscal 2019 Year-End Business Update
- Jun 14 2019 Nemaura Medical Interview to Air on Bloomberg International on the RedChip Money Report